Table of Contents
Lymphoma
Volume 2014, Article ID 160421, 6 pages
http://dx.doi.org/10.1155/2014/160421
Clinical Study

Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature

1Department of Respiratory Medicine, M. S. Ramaiah Medical College and Hospitals, MSRIT Post, Bangalore 560054, India
2Department of Medical Oncology, M. S. Ramaiah Medical College and Hospitals, MSRIT Post, Bangalore 560054, India

Received 7 July 2014; Revised 21 August 2014; Accepted 7 September 2014; Published 15 September 2014

Academic Editor: Valli De Re

Copyright © 2014 Uma Maheswari Krishnaswamy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [1 citation]

The following is the list of published articles that have cited the current article.

  • Laure-Anne Teuwen, Tom Van den Mooter, and Luc Dirix, “Management of pulmonary toxicity associated with targeted anticancer therapies,” Expert Opinion on Drug Metabolism & Toxicology, vol. 11, no. 11, pp. 1695–1707, 2015. View at Publisher ยท View at Google Scholar